Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: Effects on hemodynamics and tissue oxygenation

Shock

Volumn 41, Issue 4, 2014, Pages 269-274

  Perez, Pierre ^a   Kimmoun, Antoine ^a,b,c   Blime, Vincent ^a   Levy, Bruno ^a,b,c  

^a CHU NANCY BRABOIS   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Cardiogenic drug therapy; Hemodynamics drug effects; Myocardial infarction; Near infrared; Norepinephrine; Shock; Spectroscopy

Indexed keywords

LACTIC ACID; NORADRENALIN; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG DOSE TITRATION; FEMALE; HEART ARREST; HEART HEMODYNAMICS; HEART INDEX; HEART INFARCTION; HEART PERFORMANCE; HEART RATE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NEAR INFRARED SPECTROSCOPY; OXYGEN SATURATION; PERCUTANEOUS CORONARY INTERVENTION; PULMONARY ARTERY OCCLUSION PRESSURE; RESUSCITATION; TISSUE OXYGENATION; VENOUS BLOOD; AGED; ARTERIAL PRESSURE; COMPLICATION; DRUG ADMINISTRATION; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; MYOCARDIAL INFARCTION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SHOCK, CARDIOGENIC; YOUNG ADULT;

ADULT; AGED; ARTERIAL PRESSURE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NOREPINEPHRINE; OXYGEN CONSUMPTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SPECTROSCOPY, NEAR-INFRARED; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84897069547     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000099     Document Type: Article

References (28)

1. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD, Investigators S: Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295: 2511-2515, 2006.
2. Topalian S, Ginsberg F, Parrillo JE: Cardiogenic shock. Crit Care Med 36: S66-S74, 2008.
3. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259:H1038-H1043, 1990.
4. Okuda M: A multidisciplinary overview of cardiogenic shock. Shock 25: 557-570, 2006.
5. Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, Bertel O, Frielingsdorf J: Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97: 298-305, 2008.
6. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107: 2998-3002, 2003.
7. Reynolds HR, Hochman JS: Cardiogenic shock: current concepts and improving outcomes. Circulation 117: 686-697, 2008.
8. Levy B, Collin S, Sennoun N, Ducrocq N, Kimmoun A, Asfar P, Perez P, Meziani F: Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside. Intensive Care Med 36: 2019-2029, 2010.
9. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, et al.: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367: 1287-1296, 2012.
10. de Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779-789, 2010.
11. Levy B, Perez P, Perny J, Thivilier C, Gerard A: Comparison of norepinephrinedobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 39: 450-455, 2011.
12. Antonelli M, Levy M, Andrews PJ, Chastre J, Hudson LD, Manthous C, Meduri GU, Moreno RP, Putensen C, Stewart T, et al.: Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med 33: 575-590, 2007.
13. Werdan K, Russ M, Buerke M, Delle-Karth G, Geppert A, Schondube FA: Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int 109: 343-351, 2012.
14. Burniston JG, Ellison GM, Clark WA, Goldspink DF, Tan LB: Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovasc Toxicol 5: 355-364, 2005.
15. Ducrocq N, Kimmoun A, Furmaniuk A, Hekalo Z, Maskali F, Poussier S, Marie PY, Levy B: Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction. Anesthesiology 116: 1083-1091, 2012.
16. Bailey RW, Brengman ML, Fuh KC, Hamilton SR, Herlong HF Bulkley GB: Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock 14: 451-459, 2000.
17. de Backer D, Ospina-Tascon G, Salgado D, Favory R, Creteur J, Vincent JL: Monitoring the microcirculation in the critically ill patient: current methods and future approaches. Intensive Care Med 36: 1813-1825, 2011.
18. World Medical Association: World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 310: 2191-2194, 2013.
19. Monnet X, Osman D, Ridel C, Lamia B, Richard C, Teboul JL: Predicting volume responsiveness by using the end-expiratory occlusion in mechanically ventilated intensive care unit patients. Crit Care Med 37: 951-956, 2009.
20. Kim WY, Jun JH, Huh JW, Hong SB, Lim CM, Koh Y: Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy. Shock 40: 527-531, 2013.
21. Mayeur C, Campard S, Richard C, Teboul JL: Comparison of four different vascular occlusion tests for assessing reactive hyperemia using near-infrared spectroscopy. Crit Care Med 39: 695-701, 2011.
22. Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, et al.: Hemodynamic effects of intraaortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 37: 378-384, 2012.
23. Hollenberg SM: Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med 183: 847-855, 2011.
24. Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL: Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 36: 1882-1889, 2010.
25. Dubin A, Pozo MO, Casabella CA, Palizas F Jr, Murias G, Moseinco MC, Kanoore Edul VS, Palizas F, Estenssoro E, Ince C: Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 13:R92, 2009.
26. Creteur J, Carollo T, Soldati G, Buchele G, de Backer D, Vincent JL: The prognostic value of muscle StO2 in septic patients. Intensive Care Med 33: 1549-1556, 2007.
27. Mozina H, Podbregar M: Near-infrared spectroscopy during stagnant ischemia estimates central venous oxygen saturation and mixed venous oxygen saturation discrepancy in patients with severe left heart failure and additional sepsis/septic shock. Crit Care 14:R42, 2010.
28. Rokyta R Jr., Tesarova J, Pechman V, Gajdos P, Krouzecky A: The effects of short-term norepinephrine up-titration on hemodynamics in cardiogenic shock. Physiol Res 59: 373-378, 2010.